Literature DB >> 19442473

A high-throughput LC-MS/MS method for the quantitation of posaconazole in human plasma: Implementing fused core silica liquid chromatography.

Jennifer M Cunliffe1, Carl F Noren, Roger N Hayes, Robert P Clement, Jim X Shen.   

Abstract

A rapid and robust liquid chromatographic tandem mass spectrometric (LC-MS/MS) method for the determination of posaconazole concentrations in human plasma was validated. Posaconazole was extracted from human plasma using mixed-mode cation exchange solid phase extraction in a 96-well plate format followed by gradient separation on a fused-core Halo C18 column. The analyte and its corresponding internal standard were detected using a Sciex API 4000 triple quadrupole LC-MS/MS system equipped with a TurboIonSpray ionization source operated in the positive ion mode. The calibration range of the method was 5.00-5000ng/mL using a 50microL aliquot of plasma. The assay inter-run accuracy and precision were-4.6-2.8% and 2.3-8.7%, respectively (n=18). The results from method validation indicate the method to be sensitive, selective, accurate, and reproducible. The method was successfully applied to the routine analysis of clinical samples with the fused-core silica columns providing excellent reproducibility for greater than 1000 injections per column.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442473     DOI: 10.1016/j.jpba.2009.03.034

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

1.  Ultra-performance liquid chromatography mass spectrometry and sensitive bioassay methods for quantification of posaconazole plasma concentrations after oral dosing.

Authors:  Bertrand Rochat; Andres Pascual; Benoît Pesse; Frédéric Lamoth; Dominique Sanglard; Laurent A Decosterd; Jacques Bille; Oscar Marchetti
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin.

Authors:  Laurent Arthur Decosterd; Bertrand Rochat; Benoît Pesse; Thomas Mercier; Frédéric Tissot; Nicolas Widmer; Jacques Bille; Thierry Calandra; Boris Zanolari; Oscar Marchetti
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

3.  Detection of posaconazole by surface-assisted laser desorption/ionization mass spectrometry with dispersive liquid-liquid microextraction.

Authors:  Sheng-Yu Lin; Pin-Shiuan Chen; Sarah Y Chang
Journal:  J Am Soc Mass Spectrom       Date:  2015-01-06       Impact factor: 3.109

4.  Stability-indicating HPLC method for posaconazole bulk assay.

Authors:  Cássia V Garcia; Gislaine R Costa; Andreas S L Mendez
Journal:  Sci Pharm       Date:  2012-03-12

5.  A Comparative Study of Newly Developed HPLC-DAD and UHPLC-UV Assays for the Determination of Posaconazole in Bulk Powder and Suspension Dosage Form.

Authors:  Dalia A Hamdy; Tarek S Belal
Journal:  J Anal Methods Chem       Date:  2014-09-03       Impact factor: 2.193

6.  Fused-core particle technology in high-performance liquid chromatography: An overview.

Authors:  Joseph J Kirkland; Stephanie A Schuster; William L Johnson; Barry E Boyes
Journal:  J Pharm Anal       Date:  2013-02-27

7.  High Performance Liquid Chromatographic Assay for the Simultaneous Determination of Posaconazole and Vincristine in Rat Plasma.

Authors:  Hadeel A Khalil; Ahmed F El-Yazbi; Tarek S Belal; Dalia A Hamdy
Journal:  Int J Anal Chem       Date:  2015-12-22       Impact factor: 1.885

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.